Yatsen Holding (NYSE: YSG) CSO discloses major option grant and spouse shares
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Yatsen Holding Ltd Chief Scientific Officer Cheng Jing filed an initial statement of holdings. The filing reports share options covering 11,824,609 Class A ordinary shares at an exercise price of $0.0250 per share, expiring on February 28, 2033. These options were granted on February 28, 2023 and vest over five years, with specific tranches vesting annually from February 1, 2024 through February 1, 2028 under an award agreement. In addition, 76,000 Class A ordinary shares are reported as held indirectly through the officer’s spouse.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Cheng Jing
Role
Chief Scientific Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Share Options (Right to Buy) | -- | -- | -- |
| holding | Class A ordinary shares | -- | -- | -- |
Holdings After Transaction:
Share Options (Right to Buy) — 11,824,609 shares (Direct);
Class A ordinary shares — 76,000 shares (Indirect, By spouse)
Footnotes (1)
- [object Object]
FAQ
What does Yatsen Holding (YSG) Chief Scientific Officer report on this Form 3?
The filing reports Cheng Jing’s initial holdings in Yatsen Holding Ltd, including a large grant of share options and a smaller indirect share position held through a spouse, giving transparency into the executive’s current equity-based interests in the company.
Does this Yatsen (YSG) Form 3 show any recent insider buying or selling?
The Form 3 lists existing holdings rather than new trades. It reports share options and indirect share ownership, with transactions categorized as holdings and transaction direction marked as unknown, so it does not document explicit open-market buying or selling activity.